SILO Pharma Inc
NASDAQ:SILO
| Market Cap (Intraday) | 5.57M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.88 |
| 50-Day MA | $1.99 |
| 200-Day MA | $2.30 |
SILO Pharma Inc Stock, NASDAQ:SILO
560 Sylvan Avenue, Suite 3160, Englewood Cliffs, New Jersey 07632
United States of America
Phone: +1.718.400.9031
Number of Employees: 3
Description
Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. The company was founded by Eric Weisblum on July 13, 2010 and is headquartered in Englewood Cliffs, NJ.